Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB01220> ?p ?o ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- drugbank:DB01220 type drugbank_vocabulary:Drug assertion.
- drugbank:DB01220 label "Rifaximin [drugbank:DB01220]" assertion.
- drugbank:DB01220 seeAlso DB01220 assertion.
- drugbank:DB01220 seeAlso rifaximin.html assertion.
- drugbank:DB01220 seeAlso xif1703.shtml assertion.
- drugbank:DB01220 seeAlso xifaxan.htm assertion.
- drugbank:DB01220 identifier "drugbank:DB01220" assertion.
- drugbank:DB01220 description "Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that the drug will not pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It is used to treat diarrhea caused by E. coli." assertion.
- drugbank:DB01220 title "Rifaximin" assertion.
- drugbank:DB01220 bio2rdf_vocabulary:identifier "DB01220" assertion.
- drugbank:DB01220 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB01220 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB01220" assertion.
- drugbank:DB01220 bio2rdf_vocabulary:x-identifiers.org DB01220 assertion.
- drugbank:DB01220 drugbank_vocabulary:drugbank-id "APRD01218" assertion.
- drugbank:DB01220 drugbank_vocabulary:drugbank-id "DB01220" assertion.
- drugbank:DB01220 drugbank_vocabulary:x-cas cas:80621-81-4 assertion.
- drugbank:DB01220 drugbank_vocabulary:x-chemspider chemspider:4940837 assertion.
- drugbank:DB01220 drugbank_vocabulary:x-pubchemcompound pubchem.compound:6436173 assertion.
- drugbank:DB01220 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:46508705 assertion.
- drugbank:DB01220 drugbank_vocabulary:x-atc atc:A07AA11 assertion.
- drugbank:DB01220 drugbank_vocabulary:x-kegg kegg:D02554 assertion.
- drugbank:DB01220 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164752443 assertion.
- drugbank:DB01220 drugbank_vocabulary:x-wikipedia wikipedia:Rifaximin assertion.
- drugbank:DB01220 drugbank_vocabulary:x-ndc ndc:65649-301-03 assertion.